Skip to main content

Using the Merlin Assay for Reducing Sentinel Lymph Node Biopsy Complications in Melanoma: A Retrospective Cohort Study

Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study

Authors: Hieken TJ, Sadurní MB, Quattrocchi E, Kobic A, Sominidi-Damodaran S, Dwarkasing JT, Meerstein-Kessel L, Bridges AG, Meves A.

Int J Dermatol. 2022 Jan 31. doi: 10.1111/ijd.16056. Online ahead of print.

Disclaimer: Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Specialties: Dermatology, Oncology